Observational Study of Patients Receiving Dupixent® for Atopic Dermatitis (AD)

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Observational Study of Patients Receiving Dupixent® for Atopic Dermatitis (AD)	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, skin disorder	Active, not recruiting	Not stated	2026-08-06		NCT03992417

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Regeneron Pharmaceuticals	238
Sanofi	254

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.

Clinical trials